Organogenesis Launches Regenerative Medicine College Scholarship

* Reuters is not responsible for the content in this press release.

Wed Jun 10, 2009 3:44pm EDT

Canton High School Senior Is First Recipient

CANTON, Mass., June 10 /PRNewswire/ -- Organogenesis, Inc., a leading
regenerative medicine company, has established an annual scholarship program
with Canton High School to honor a graduating senior pursuing a career in life
sciences research or biomedical engineering. The 2009 recipient is Justin
Gaines, who will be attending Brandeis University this fall. As part of the
newly launched Canton High School Externship Program, Justin worked this past
year with Organogenesis' Applied Cell Research Group, assisting in the group's
regenerative medicine research program.

"As a multidisciplinary field, regenerative medicine requires a diverse team
of scientific and medical professionals to advance the science of growing
living cells, tissues and organs in the laboratory, and then translate it into
technologies that improve the lives of patients," said Gary Gillheeney, Chief
Operating Officer and Chief Financial Officer of Organogenesis. "We are proud
to support Justin in his career goals and we hope his example will inspire
other talented young men and women to consider a career in life sciences
research or engineering."

The Organogenesis Scholarship of $2,500.00 is awarded on the basis of academic
achievement and content of an essay, "How do you see yourself contributing to
the future of the Life Sciences?" Justin's essay detailed his career goal in
"the diagnostic imaging and diagnosis of diseases, along with appropriate
courses of treatment."

Justin is graduating in the top 15 percent of his class, with a GPA above 3.5.
As an extern at Organogenesis under the auspices of Dr. Dolores Baksh,
Associate Director of Applied Research, Justin was involved in the evaluation
of the potency of cells used in regenerative medicine therapies; assisted in
the design and execution of experiments aimed at improving therapies for wound
healing; and gained exposure to the cultivation of a number of different cell
types.

About Canton High School
Canton High School is located at 900 Washington Street in Canton, MA. The
facility completed a major building renovation in 2007 that included a
substantial increase in instructional technology. The mission of Canton High
School is to educate all students in a challenging, safe, disciplined,
creative and nurturing atmosphere to become lifelong learners whose
achievements and contributions are a credit to themselves and to society.
Canton High School's science department offers courses in biological,
chemical, and physical science and applied technology. In addition, elective
courses are offered in several areas of science and technology. The newly
launched Canton High School Externship Program places students with local
companies to gain practical career experience. 

About Regenerative Medicine
A new frontier in healthcare, regenerative medicine utilizes living human
cells to repair or replace body tissue damaged by injury, disease or even the
natural aging process.  Regenerative medicine is a multidisciplinary field
which brings together biology, medicine, and engineering to empower scientists
to grow living cells, tissues and organs in the laboratory, and to safely
implant them into the human body for the purposes of healing.
 
About Organogenesis, Inc.
Having pioneered the field, Massachusetts based Organogenesis, Inc. is a world
leading regenerative medicine company focused in the areas of bio-active wound
healing, oral regeneration and bio-surgery. The company's mission is to bring
the medical marvel of regenerative medicine products to patients and to
standardize their use in everyday medical care. Organogenesis recently
established European headquarters located in Switzerland, as well as announced
an expansion of its U.S. headquarters.  For more information, visit
www.organogenesis.com.  




SOURCE  Organogenesis, Inc.

Angelyn Lowe of Organogenesis, Inc., +1-858-273-1805, alowe@chasepr.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.